Search
Now showing items 21-30 of 30
Coronary syndrome Y: Should we focus more on extra-cardiac conditions including renal disease and its management?
(ELSEVIER IRELAND LTD, 2011)
…
Left ventricular outflow tract myxoma accompanied by dextrocardia with situs inversus: a case report
(SPRINGER, 2007)
Myxoma is the most frequently encountered primary tumour of the heart, comprising more than 50% of all benign cardiac tumours. The case presented here was diagnosed as having dextrocardia with situs inversus and concomitant ...
Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure
(SPRINGER, 2009)
Severe heart failure represents a major source of morbidity and mortality. Poor right ventricular function is an independent prognostic marker for mortality in patients with chronic heart failure. In this study, levosimendan ...
Levosimendan improves renal function in patients with acute decompensated heart failure: Comparison with dobutamine
(SPRINGER, 2007)
Background Levosimendan is a relatively new cardiac inotropic agent with calcium sensitizing activity. This study was conducted to investigate the effects of levosimendan (L) and dobutamine (D) on renal function in patients ...
Free-floating biatrial thrombi with concomitant saddle pulmonary embolism
(ELSEVIER IRELAND LTD, 2010)
Free-floating intracardiac thrombi represent a severe yet uncommon condition and mostly coexist with thromboembolism. Notably, mobile right heart thrombus can occur in patients with massive pulmonary embolism. Early diagnosis ...
Cytokines: Potential contributors to arrhythmogenesis in demyelinating syndromes?
(ELSEVIER IRELAND LTD, 2011)
…
Efficacy of levosimendan in patients with chronic heart failure: Does rhythm matter?
(AVES YAYINCILIK, 2010)
Objective: Leyosimendan is a relatively new inotropic agent. Unlike other inotropic agents, Levosimendan does not increase cellular calcium intake, so that, does not cause intracellular calcium overload and related ...
Acute Effects of Levosimendan and Dobutamine on QRS Duration in Patients with Heart Failure
(ARQUIVOS BRASILEIROS CARDIOLOGIA, 2010)
Background: Levosimendan is a novel inotropic agent that enhances cardiac contractility without increasing cellular calcium intake, so that it is not supposed to cause intracellular calcium overload and related arrhythmias. ...
Crimean-Congo hemorrhagic fever: does it involve the heart?
(ELSEVIER SCI LTD, 2009)
Objective: Crimean-Congo hemorrhagic fever (CCHF) is an acute viral hemorrhagic fever with a high mortality rate. Despite increasing knowledge about viral hemorrhagic fevers, the pathogenesis of CCHF and causes of death ...
Genetic basis of sudden cardiac death due to emotional trauma in apparently healthy individuals
(ELSEVIER IRELAND LTD, 2010)
…